You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CBFA2T3-GLIS2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

3T MRI T2 Mapping Technique in Chondro-labral Pathology of Hip,

Not yet recruiting
  • Hip Injuries and Disorders
  • Hip Arthrosis
  • T2 mapping 3T MRI + hip arthroscopy
  • Bologna, Italy
    Istituto Ortopedico Rizzoli
Sep 28, 2023

Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes Trial in Cairo (Radiofrequency stellate ganglion

Not yet recruiting
  • Stellate Ganglion
  • +3 more
  • Radiofrequency stellate ganglion block using ultrasound guidance (SGB)
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Sep 5, 2023

Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)

Not yet recruiting
  • Prostate Cancer
  • [99mTc]Tc-PSMA-T4
  • (no location specified)
Apr 26, 2023

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

Recruiting
  • Locally Advanced Nasopharyngeal Carcinoma
  • 2 cycles induction chemotherapy
  • 3 cycles induction chemotherapy
  • Guangzhou, Other (Non U.s.), China
    First Affiliated Hospital, Sun Yat-Sen University
May 6, 2023

T2DM (Type 2 Diabetes) Trial in Nanjing (Ecnoglutide, Placebo)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Jan 10, 2023

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

T2DM (Type 2 Diabetes) Trial in Shanghai (Ecnoglutide high dosage, Ecnoglutide low dosage, Dulaglutide)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Ecnoglutide high dosage
  • +3 more
  • Shanghai, Shanghai, China
    ZHONGSHAN Hospital
Dec 25, 2022

T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • DWP16001 0.3 mg
  • (no location specified)
Nov 15, 2023

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Recruiting
  • Acute Lymphoblastic Leukemia
  • Large B-cell Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture

Completed
  • Neat OGTT
  • +2 more
  • TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
  • New Brunswick, New Jersey
    Rutgers, Department of Nutritional Sciences
Jun 2, 2023

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Adults With Severe Eosinophilic Asthma on Benralizumab.

Active, not recruiting
  • Severe Eosinophilic Asthma
  • Survey Administration
  • Calgary, Alberta, Canada
  • +19 more
Dec 1, 2022

Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)

Not yet recruiting
  • Concussion, Mild
  • Omega-3
  • Placebo
  • Winnipeg, Manitoba, Canada
    Applied Research Centre, Faculty of Kinesiology, University of M
Apr 27, 2023

Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

Completed
  • Healthy
  • R1: Reference Product X
  • +12 more
  • Nottingham, United Kingdom
    Quotient Sciences
Dec 7, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • GD2 CAR T cells
  • (no location specified)
Sep 15, 2022

Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Nivolumab
  • Ipilimumab
  • Saint Louis, Missouri
  • +11 more
Dec 15, 2022

Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,

Recruiting
  • Elbow Fracture
  • +2 more
  • Lactose Placebo
  • +2 more
  • Baltimore, Maryland
  • +16 more
Dec 8, 2022

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Pulse Oximetry With Different Oximeters and Arterial Saturation:

Not yet recruiting
  • Respiratory Failure
  • +2 more
  • SpO2 and SaO2 comparison
  • Montréal, Quebec, Canada
  • +2 more
Oct 25, 2023

Breast Cancer Trial in Detroit (biological, drug, other)

Terminated
Has Results
  • Breast Cancer
  • HER2Bi-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 29, 2022